Elsevier's Arezzo Puts GPs at the Vanguard of Improved Cancer Diagnosis

ElsevierElsevier, a world-leading provider of scientific, technical, and medical information products and services, is now able to support primary care clinicians and others to deliver high quality care in areas such as cancer diagnoses, referral rates and self-care through Arezzo, its active clinical decision support (CDS) technology. The product will be on show at EHI Live 2015, the UK's largest digital health event, 3rd to 4th November.

Arezzo is an active CDS inference engine. By integrating with clinical systems, Arezzo matches appropriate evidence-based guidelines with patient information and dynamically evaluates best practice options in light of the current patient and disease information.

Robert Dunlop, clinical director of Elsevier Clinical Solutions, will demonstrate how Arezzo Pathways can be used to implement the latest NICE guidelines for early cancer diagnosis and so address issues over increased mortality rates reported in a recent study published in the British Medical Journal. In addition Dunlop will highlight how Arezzo has been proven to help improve the use of similar protocols in the treatment of stroke in New Zealand. His talk will be part of the Digital Primary Care conference track, which Elsevier is sponsoring.

"CDS should make the right thing to do, the easy thing to do. Yet in reality not all such systems deliver improved patient outcomes, and can prove an obstacle to better care. With Arezzo, it can be shown that putting active evidence-based guidelines in the hands of GPs directly at the point of care can help improve clinical practice," Dunlop said.

Arezzo can help GPs make a cancer diagnosis much more quickly and with much more confidence by applying the latest NICE recommendations to an individual patient’s symptoms. It can also perform a 'safety-netting' function so that patients with vague symptoms are flagged for follow up. Early diagnosis can help improve chances of cancer survival, and missed diagnoses are a real concern for the clinical community.

Dunlop will also show how that, by using such technology to provide the right individual with the right information in ways that make most sense, evidence-based advice can be used across the patient journey to deliver responsive, effective and personalised care.

British GPs can now benefit from the same technology, which is in use in more than 1,000 GP practices in New Zealand. Arezzo was shown to have halved the number of hospital admissions for childhood asthma in one trial in the country, and has helped increase the use of clinical guidelines for stroke patients by delivering evidence-based content at the point of care.

Arezzo supports clinicians by identifying the optimal treatment path specific to each patient, and matching the appropriate evidence-based guidelines with patient information to provide a number of best practice recommendations for the clinician to choose from. This innovative use of computer-interpretable guidelines has a proven track record across multiple care settings, from patient self-care advice via online health and symptom checkers through to telephone triage services.

Greater self-care, increased role for primary care and more personalised services are at the heart of the NHS’ urgent and emergency care review. Central to this, and to wider policy initiatives, is the need to reduce the amount of unacceptable variation in clinical care that means that patients in one part of the country get different care to those elsewhere.

Enabling GPs to be at the vanguard of delivering better care for better value will be key themes at the Digital Primary Care conference track, which takes place on 3rd November as part of EHI Live. This conference track will also discuss the remote monitoring of patients, patient activation, asset and resource optimisation, and the need for patient information to be available digitally to all healthcare professionals. Speakers from NHS England will outline the next steps for digital primary care, and include Beverley Bryant, director of strategic systems and technology, Tracey Grainger, head of digital primary care development, and Indi Singh, head of enterprise architecture and interoperability champion.

EHI Live takes place on 3rd and 4th November 2015 at the NEC, Birmingham. Elsevier Clinical Solutions will be exhibiting at stand A74. Robert Dunlop will be speaking at 11.45 on 3rd November as part of the Digital Primary Care conference stream.

About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey - and publishes more than 2,500 journals, including The Lancet and Cell, and more than 33,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group plc, a world-leading provider of information solutions for professional customers across industries.

Most Popular Now

Stanford Medicine Study Suggests Physici…

Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, even when they are complex. But how do chatbots do when guiding treatment and care after the diagnosis? For...

OmicsFootPrint: Mayo Clinic's AI To…

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images. The details of the tool...

Adults don't Trust Health Care to U…

A study finds that 65.8% of adults surveyed had low trust in their health care system to use artificial intelligence responsibly and 57.7% had low trust in their health care...

Testing AI with AI: Ensuring Effective A…

Using a pioneering artificial intelligence platform, Flinders University researchers have assessed whether a cardiac AI tool recently trialled in South Australian hospitals actually has the potential to assist doctors and...

AI Unlocks Genetic Clues to Personalize …

A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes - insights that could help doctors tailor...

The 10 Year Health Plan: What do We Need…

Opinion Article by Piyush Mahapatra, Consultant Orthopaedic Surgeon and Chief Innovation Officer at Open Medical. There is a new ten-year plan for the NHS. It will "focus efforts on preventing, as...

Deep Learning to Increase Accessibility…

Coronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor heart disease, myocardial perfusion imaging (MPI) by single photon...

People's Trust in AI Systems to Mak…

Psychologists warn that AI's perceived lack of human experience and genuine understanding may limit its acceptance to make higher-stakes moral decisions. Artificial moral advisors (AMAs) are systems based on artificial...

AI Model can Read ECGs to Identify Femal…

A new AI model can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG). The researchers say the algorithm, designed specifically for female patients...

Relationship Between Sleep and Nutrition…

Diet and sleep, which are essential for human survival, are interrelated. However, recently, various services and mobile applications have been introduced for the self-management of health, allowing users to record...

New AI Tool Mimics Radiologist Gaze to R…

Artificial intelligence (AI) can scan a chest X-ray and diagnose if an abnormality is fluid in the lungs, an enlarged heart or cancer. But being right is not enough, said...

DMEA 2025 - Innovations, Insights and Ne…

8 - 10 April 2025, Berlin, Germany. Less than 50 days to go before DMEA 2025 opens its doors: Europe's leading event for digital health will once again bring together experts...